Dimitrios H Roukos. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antineoplastic Agents/therapeutic useBiomedical ResearchClinical Trials as TopicDrug ApprovalDrug DesignErbB Receptors/antagonists & inhibitorsFemaleHumansNeoplasms/therapyProto-Oncogene Proteins/geneticsProto-Oncogene Proteins B-raf/geneticsProto-Oncogene Proteins p21(ras)ras Proteins/genetics
Substances: See more » Antineoplastic AgentsKRAS protein, humanProto-Oncogene ProteinsErbB ReceptorsBRAF protein, humanProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)ras Proteins
Year: 2009 PMID: 19379079 DOI: 10.1586/erm.09.7
Source DB: PubMed Journal: Expert Rev Mol Diagn ISSN: 1473-7159 Impact factor: 5.225